rs7932437

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_015080.4(NRXN2):​c.*1164A>G variant causes a downstream gene change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.516 in 152,008 control chromosomes in the GnomAD database, including 23,728 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.52 ( 23717 hom., cov: 31)
Exomes 𝑓: 0.57 ( 11 hom. )

Consequence

NRXN2
NM_015080.4 downstream_gene

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -1.53

Publications

11 publications found
Variant links:
Genes affected
NRXN2 (HGNC:8009): (neurexin 2) This gene encodes a member of the neurexin gene family. The products of these genes function as cell adhesion molecules and receptors in the vertebrate nervous system. These genes utilize two promoters. The majority of transcripts are produced from the upstream promoter and encode alpha-neurexin isoforms while a smaller number of transcripts are produced from the downstream promoter and encode beta-neuresin isoforms. The alpha-neurexins contain epidermal growth factor-like (EGF-like) sequences and laminin G domains, and have been shown to interact with neurexophilins. The beta-neurexins lack EGF-like sequences and contain fewer laminin G domains than alpha-neurexins. Alternative splicing and the use of alternative promoters may generate thousands of transcript variants (PMID: 12036300, PMID: 11944992).[provided by RefSeq, Jun 2010]
NRXN2 Gene-Disease associations (from GenCC):
  • autism
    Inheritance: AD Classification: STRONG, LIMITED Submitted by: G2P, Ambry Genetics
  • neurodevelopmental disorder
    Inheritance: AR Classification: LIMITED Submitted by: Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.93).
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.692 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
NRXN2NM_015080.4 linkc.*1164A>G downstream_gene_variant ENST00000265459.11 NP_055895.1 Q9P2S2-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
NRXN2ENST00000265459.11 linkc.*1164A>G downstream_gene_variant 5 NM_015080.4 ENSP00000265459.5 Q9P2S2-1
NRXN2ENST00000704782.1 linkc.*1164A>G downstream_gene_variant ENSP00000516031.1 A0A994J5C3

Frequencies

GnomAD3 genomes
AF:
0.517
AC:
78466
AN:
151834
Hom.:
23722
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.215
Gnomad AMI
AF:
0.840
Gnomad AMR
AF:
0.505
Gnomad ASJ
AF:
0.682
Gnomad EAS
AF:
0.225
Gnomad SAS
AF:
0.580
Gnomad FIN
AF:
0.576
Gnomad MID
AF:
0.655
Gnomad NFE
AF:
0.697
Gnomad OTH
AF:
0.559
GnomAD4 exome
AF:
0.571
AC:
32
AN:
56
Hom.:
11
AF XY:
0.528
AC XY:
19
AN XY:
36
show subpopulations
African (AFR)
AF:
0.500
AC:
1
AN:
2
American (AMR)
AC:
0
AN:
0
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
2
East Asian (EAS)
AC:
0
AN:
0
South Asian (SAS)
AC:
0
AN:
0
European-Finnish (FIN)
AF:
0.571
AC:
8
AN:
14
Middle Eastern (MID)
AC:
0
AN:
0
European-Non Finnish (NFE)
AF:
0.600
AC:
18
AN:
30
Other (OTH)
AF:
0.625
AC:
5
AN:
8
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.495
Heterozygous variant carriers
0
1
1
2
2
3
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.516
AC:
78480
AN:
151952
Hom.:
23717
Cov.:
31
AF XY:
0.510
AC XY:
37882
AN XY:
74268
show subpopulations
African (AFR)
AF:
0.215
AC:
8908
AN:
41482
American (AMR)
AF:
0.504
AC:
7702
AN:
15268
Ashkenazi Jewish (ASJ)
AF:
0.682
AC:
2367
AN:
3472
East Asian (EAS)
AF:
0.225
AC:
1162
AN:
5162
South Asian (SAS)
AF:
0.579
AC:
2778
AN:
4796
European-Finnish (FIN)
AF:
0.576
AC:
6066
AN:
10532
Middle Eastern (MID)
AF:
0.663
AC:
195
AN:
294
European-Non Finnish (NFE)
AF:
0.697
AC:
47354
AN:
67926
Other (OTH)
AF:
0.561
AC:
1182
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
1598
3196
4795
6393
7991
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
672
1344
2016
2688
3360
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.602
Hom.:
26460
Bravo
AF:
0.498
Asia WGS
AF:
0.393
AC:
1367
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.93
CADD
Benign
0.13
DANN
Benign
0.44
PhyloP100
-1.5

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs7932437; hg19: chr11-64373504; API